{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:58:38Z","timestamp":1778173118734,"version":"3.51.4"},"reference-count":30,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"unspecified","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871311"],"award-info":[{"award-number":["81871311"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071855"],"award-info":[{"award-number":["82071855"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Clinical Research Center for Obstetrics and Gynecology","award":["BYSYSZKF2022008"],"award-info":[{"award-number":["BYSYSZKF2022008"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,5,20]]},"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome (PCOS), recognised as the predominant aetiological factor in ovulatory dysfunction-related infertility, accounts for approximately 70% of anovulatory infertility cases. Patients with PCOS have significantly higher anti-M\u00fcllerian hormone (AMH) levels than their counterparts undergoing in vitro fertilisation (IVF) for non-PCOS indications (eg, male\/tubal factors). Several studies have suggested that a high AMH level is associated with adverse pregnancy outcomes in IVF, particularly preterm delivery. However, most of these studies are retrospective studies, and their results are inconsistent. The majority of AMH measurements are conducted before pregnancy; however, AMH levels fluctuate dynamically during pregnancy. There is a pressing need for a well-structured prospective study to definitively establish whether high AMH levels during pregnancy are associated with IVF\/intracytoplasmic sperm injection (ICSI) pregnancy outcomes in PCOS patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This prospective cohort study will be conducted at four reproductive medicine centres. The plan is to enrol 1,320 PCOS patients and 1320 non-PCOS women who undergo IVF\/ICSI and achieve singleton clinical pregnancies. Serum samples will be collected at about 6 weeks of gestation to measure the serum AMH level. Follow-up visits will be conducted at 12, 28 and 37 weeks of gestation, delivery and 6 weeks after delivery to obtain information about pregnancy outcomes and complications. The primary outcome is preterm delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The study was approved by the Medical Research Ethics Committee of Peking University Third Hospital (M2022618). Informed consent will be obtained from all patients. The results of this clinical study will be presented at scientific conferences and submitted to a peer-reviewed journal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>ChiCTR2300068554.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-093543","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T23:25:22Z","timestamp":1749597922000},"page":"e093543","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Association between anti-M\u00fcllerian hormone levels during pregnancy and pregnancy outcomes in infertile patients undergoing in vitro fertilisation\/intracytoplasmic sperm injection: protocol for a multicentre prospective cohort study"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4260-2240","authenticated-orcid":false,"given":"Qiong","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Center for Reproductive Medicine, Peking University Third Hospital, Beijing, China"},{"name":"National Clinical Research Center for Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2788-4614","authenticated-orcid":false,"given":"Kai-Lun","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Center for Reproductive Medicine, Peking University Third Hospital, Beijing, China"},{"name":"National Clinical Research Center for Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China"},{"name":"Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Peking University Third Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Peking University Third Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shulin","family":"Yang","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Huazhong University of Science and Technology, Tongji Medical College, Tongji Hospital, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Chu","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Huazhong University of Science and Technology, Tongji Medical College, Tongji Hospital, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honghong","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Children\u2019s Hospital of Shanxi, Taiyuan, Shanxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiwen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yue","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Huazhong University of Science and Technology, Tongji Medical College, Tongji Hospital, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guimin","family":"Hao","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueqing","family":"Wu","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, Children\u2019s Hospital of Shanxi, Taiyuan, Shanxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Center for Reproductive Medicine, Peking University Third Hospital, Beijing, China"},{"name":"National Clinical Research Center for Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China"},{"name":"Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Peking University Third Hospital, Beijing, China"},{"name":"Key Laboratory of Assisted Reproduction (Peking University), Ministry of Education, Beijing, China"},{"name":"State Key Laboratory of Female Fertility Promotion, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0305-5579","authenticated-orcid":false,"given":"Rong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Center for Reproductive Medicine, Peking University Third Hospital, Beijing, China"},{"name":"National Clinical Research Center for Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China"},{"name":"Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology, Peking University Third Hospital, Beijing, China"},{"name":"Key Laboratory of Assisted Reproduction (Peking University), Ministry of Education, Beijing, China"},{"name":"State Key Laboratory of Female Fertility Promotion, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"2025121222232985000_15.6.e093543.1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/det262"},{"key":"2025121222232985000_15.6.e093543.2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dew218"},{"key":"2025121222232985000_15.6.e093543.3","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmi036"},{"key":"2025121222232985000_15.6.e093543.4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3886"},{"key":"2025121222232985000_15.6.e093543.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.10.043"},{"key":"2025121222232985000_15.6.e093543.6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.rbmo.2019.03.203","article-title":"A meta-analysis of pregnancy-related outcomes and complications in women with polycystic ovary syndrome undergoing IVF","volume":"39","author":"Sha","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"2025121222232985000_15.6.e093543.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2016.01.010"},{"key":"2025121222232985000_15.6.e093543.8","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/09513590.2018.1431770","article-title":"Steroid-depleted polycystic ovarian syndrome serum promotes in vitro oocyte maturation and embryo development","volume":"34","author":"Eyvaznejad","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"2025121222232985000_15.6.e093543.9","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)00954-5","article-title":"Miscarriage: worldwide reform of care is needed","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"2025121222232985000_15.6.e093543.10","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod66.2.297"},{"key":"2025121222232985000_15.6.e093543.11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.rbmo.2018.05.003","article-title":"Cumulative live birth rates after IVF in patients with polycystic ovaries: phenotype matters","volume":"37","author":"De Vos","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"2025121222232985000_15.6.e093543.12","article-title":"Clinical Applications of Serum Anti-M\u00fcllerian Hormone Measurements in Both Males and Females: An Update","volume":"2","author":"Xu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"2025121222232985000_15.6.e093543.13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.5935\/1518-0557.20200094","article-title":"High anti-M\u00fcllerian hormone levels might not reflect the likelihood of clinical pregnancy rate in IVF\/ICSI treatment","volume":"25","author":"Sun","year":"2021","journal-title":"JBRA Assist Reprod"},{"key":"2025121222232985000_15.6.e093543.14","doi-asserted-by":"crossref","DOI":"10.1242\/dev.197459","article-title":"Blocking estrogen-induced AMH expression is crucial for normal follicle formation","volume":"148","author":"Tanimoto","year":"2021","journal-title":"Development"},{"key":"2025121222232985000_15.6.e093543.15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1507\/endocrj.EJ16-0501","article-title":"Relationship between serum anti-Mullerian hormone and clinical parameters in polycystic ovary syndrome","volume":"64","author":"Matsuzaki","year":"2017","journal-title":"Endocr J"},{"key":"2025121222232985000_15.6.e093543.16","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.673284","article-title":"High Serum Anti-M\u00fcllerian Hormone Concentrations Are Associated With Poor Pregnancy Outcome in Fresh IVF\/ICSI Cycle but Not Cumulative Live Birth Rate in PCOS Patients","volume":"12","author":"Guo","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025121222232985000_15.6.e093543.17","doi-asserted-by":"crossref","DOI":"10.1186\/s12958-020-00581-4","article-title":"High serum Antimullerian hormone levels are associated with lower live birth rates in women with polycystic ovarian syndrome undergoing assisted reproductive technology","volume":"18","author":"Tal","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"2025121222232985000_15.6.e093543.18","doi-asserted-by":"crossref","DOI":"10.1186\/s12884-022-04591-5","article-title":"Serum anti-M\u00fcllerian hormone levels are associated with early miscarriage in the IVF\/ICSI fresh cycle","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"2025121222232985000_15.6.e093543.19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.rbmo.2021.08.016","article-title":"High serum anti-M\u00fcllerian hormone concentrations have a negative impact on fertilization and embryo development rates","volume":"44","author":"Tsai","year":"2022","journal-title":"Reprod Biomed Online"},{"key":"2025121222232985000_15.6.e093543.20","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.724333","article-title":"Comparison of Cumulative Live Birth Rate Between Aged PCOS Women and Controls in IVF\/ICSI Cycles","volume":"12","author":"Mai","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025121222232985000_15.6.e093543.21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ajog.2014.02.026","article-title":"Characterization of women with elevated antim\u00fcllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes","volume":"211","author":"Tal","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"2025121222232985000_15.6.e093543.22","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1210\/jc.2018-01320","article-title":"M\u00fcllerian-Inhibiting Substance\/Anti-M\u00fcllerian Hormone as a Predictor of Preterm Birth in Polycystic Ovary Syndrome","volume":"103","author":"Hsu","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2025121222232985000_15.6.e093543.23","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.fertnstert.2019.09.039","article-title":"High antim\u00fcllerian hormone levels are associated with preterm delivery in patients with polycystic ovary syndrome","volume":"113","author":"Hu","year":"2020","journal-title":"Fertil Steril"},{"key":"2025121222232985000_15.6.e093543.24","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.788000","article-title":"Elevated Anti-M\u00fcllerian Hormone Is an Independent Risk Factor for Preterm Birth Among Patients With Overweight Polycystic Ovary Syndrome","volume":"12","author":"Du","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025121222232985000_15.6.e093543.25","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.fertnstert.2023.07.011","article-title":"Elevated antim\u00fcllerian hormone levels are not associated with preterm delivery after in vitro fertilization or ovulation induction","volume":"120","author":"Kim","year":"2023","journal-title":"Fertil Steril"},{"key":"2025121222232985000_15.6.e093543.26","doi-asserted-by":"crossref","first-page":"e1116","DOI":"10.1210\/clinem\/dgae324","article-title":"High AMH Levels Are Associated With Gestational Hypertension in Patients With PCOS who Underwent IVF\/ICSI-ET","volume":"110","author":"Zhang","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2025121222232985000_15.6.e093543.27","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1081069","article-title":"Serum anti-M\u00fcllerian hormone levels are associated with perinatal outcomes in women undergoing IVF\/ICSI: A multicenter retrospective cohort study","volume":"14","author":"He","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025121222232985000_15.6.e093543.28","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00404-016-4274-8","article-title":"Retrospective cohort study: AMH is the best ovarian reserve markers in predicting ovarian response but has unfavorable value in predicting clinical pregnancy in GnRH antagonist protocol","volume":"295","author":"Xu","year":"2017","journal-title":"Arch Gynecol Obstet"},{"key":"2025121222232985000_15.6.e093543.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2010.09.012"},{"key":"2025121222232985000_15.6.e093543.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2003.10.004"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-093543","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:23:38Z","timestamp":1765607018000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-093543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,10]]},"published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1136\/bmjopen-2024-093543"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-093543","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}